Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Andrews

Showing results (1-10 of 364) with videos related to

Pageof 37
Sort By:
Biologicals : Journal of the International Association of Biological Standardization|October 12, 2011
Epidemiological designs for vaccine safety assessment: methods and pitfallsNick Andrews
BMJ (Clinical Research Ed.)|September 23, 2024
Vaccination to prevent mpoxNick Andrews, Sema Mandal
Current Opinion in Pharmacology|March 8, 2011
It might be a big family but the pain remains-last chance saloon for selective 5-HT receptor ligands?Nick Andrews, Michael F O'Neill
Clinical and Diagnostic Laboratory Immunology|September 11, 2003
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in EnglandNick Andrews, Ray Borrow, Elizabeth Miller
Vaccine|July 9, 2005
Model selection methodology for inter-laboratory standardisation of antibody titresGeorge Kafatos, Nick Andrews, Anthony Nardone, et al.
Vaccine|March 2, 2017
No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in EnglandNick Andrews, Julia Stowe, Elizabeth Miller
Vaccine|June 3, 2020
Nephrotic syndrome in infants and toddlers before and after introduction of the meningococcal B vaccine programme in England: An ecological studyNick Andrews, Julia Stowe, Elizabeth Miller
Tropical Medicine & International Health : TM & IH|March 11, 2010
Clustered lot quality assurance sampling to assess immunisation coverage: increasing rapidity and maintaining precisionLorenzo Pezzoli, Nick Andrews, Olivier Ronveaux
CNS Drugs|October 3, 2019
Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and NarcolepsyJulia Stowe, Nick Andrews, Elizabeth Miller
Plos Medicine|July 4, 2019
Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling studyYoon Hong Choi, Nick Andrews, Elizabeth Miller
Pageof 37

Showing results (1-10 of 364) with videos related to

Sort By:
Pageof 37
Biologicals : Journal of the International Association of Biological Standardization|October 12, 2011
Epidemiological designs for vaccine safety assessment: methods and pitfallsNick Andrews
BMJ (Clinical Research Ed.)|September 23, 2024
Vaccination to prevent mpoxNick Andrews, Sema Mandal
Current Opinion in Pharmacology|March 8, 2011
It might be a big family but the pain remains-last chance saloon for selective 5-HT receptor ligands?Nick Andrews, Michael F O'Neill
Clinical and Diagnostic Laboratory Immunology|September 11, 2003
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in EnglandNick Andrews, Ray Borrow, Elizabeth Miller
Vaccine|July 9, 2005
Model selection methodology for inter-laboratory standardisation of antibody titresGeorge Kafatos, Nick Andrews, Anthony Nardone, et al.
Vaccine|March 2, 2017
No increased risk of Guillain-Barré syndrome after human papilloma virus vaccine: A self-controlled case-series study in EnglandNick Andrews, Julia Stowe, Elizabeth Miller
Vaccine|June 3, 2020
Nephrotic syndrome in infants and toddlers before and after introduction of the meningococcal B vaccine programme in England: An ecological studyNick Andrews, Julia Stowe, Elizabeth Miller
Tropical Medicine & International Health : TM & IH|March 11, 2010
Clustered lot quality assurance sampling to assess immunisation coverage: increasing rapidity and maintaining precisionLorenzo Pezzoli, Nick Andrews, Olivier Ronveaux
CNS Drugs|October 3, 2019
Do Vaccines Trigger Neurological Diseases? Epidemiological Evaluation of Vaccination and Neurological Diseases Using Examples of Multiple Sclerosis, Guillain-Barré Syndrome and NarcolepsyJulia Stowe, Nick Andrews, Elizabeth Miller
Plos Medicine|July 4, 2019
Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling studyYoon Hong Choi, Nick Andrews, Elizabeth Miller
Pageof 37